Ionis Pharmaceuticals
IONS
#1567
Rank
โ‚น1.188 T
Marketcap
โ‚น7,338
Share price
-0.16%
Change (1 day)
127.42%
Change (1 year)

Revenue for Ionis Pharmaceuticals (IONS)

Revenue in 2025 (TTM): โ‚น83.35 Billion

According to Ionis Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น86.86 Billion. In 2024 the company made a revenue of โ‚น60.49 Billion a decrease over the revenue in the year 2023 that were of โ‚น65.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ionis Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น83.35 B37.8%
2024 โ‚น60.49 B-7.75%
2023 โ‚น65.57 B34.91%
2022 โ‚น48.60 B-19.43%
2021 โ‚น60.32 B13.1%
2020 โ‚น53.33 B-33.38%
2019 โ‚น80.05 B90.92%
2018 โ‚น41.93 B26.61%
2017 โ‚น33.11 B40.6%
2016 โ‚น23.55 B24.93%
2015 โ‚น18.85 B38.9%
2014 โ‚น13.57 B49.17%
2013 โ‚น9.09 B62.85%
2012 โ‚น5.58 B6.6%
2011 โ‚น5.24 B7.84%
2010 โ‚น4.86 B-13.85%
2009 โ‚น5.64 B19.54%
2008 โ‚น4.72 B72.75%
2007 โ‚น2.73 B151.48%
2006 โ‚น1.08 B-39.84%
2005 โ‚น1.80 B-2.17%
2004 โ‚น1.84 B-18.89%
2003 โ‚น2.27 B-40.81%
2002 โ‚น3.84 B49.58%
2001 โ‚น2.57 B47.84%
2000 โ‚น1.73 B17.98%
1999 โ‚น1.47 B-11.36%
1998 โ‚น1.66 B30.57%
1997 โ‚น1.27 B56.72%
1996 โ‚น0.81 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚น12.49 B-85.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas